It summarizes clinical trial results with new evidence on adherence, demographics and emerging indications and explains what it all means for patients and providers
5 Mutations in TP53 are thought to occur in more than 50% of all human malignancies
This catch-all code applies when a more specific J-code does not exist for the drug
Please consult your healthcare practitioner before use, especially if you are pregnant or nursing, to make an informed decision towards enhancing your well-being.
Hand filler treatments are generally well-tolerated and cause minimal discomfort
COJEC drugs: cisplatin (Santa Cruz Biotechnology, sc-200896), vincristine (Santa Cruz Biotechnology, sc-201434), etoposide (Santa Cruz Biotechnology, sc-3512), cyclophosphamide (Santa Cruz Biotechnology, sc-361165), and carboplatin (Santa Cruz Biotechnology, sc-202093A)